Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: An analysis from UNOS/OPTN database

Clinical Transplantation

Volumn 28, Issue 7, 2014, Pages 755-761

  Wong, Robert J ^a   Ahmed, Aijaz ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholic liver disease; Hepatitis C; Hepatocellular carcinoma; Racial disparities

Indexed keywords

ADULT; AFRICAN AMERICAN; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC LIVER DISEASE; ETHNIC DIFFERENCE; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; COMPLICATION; ETHNIC GROUP; FOLLOW UP; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MORTALITY; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84903776110     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12374     Document Type: Article

References (28)

1. Hoyert DL, Xu J. Deaths: Preliminary data for 2011. National Vital Statistics Reports Vol 61 No 6. Hyattsville, MD: National Center for Health Statistics, 2012. Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_06.pdf
2. Kim WR, Terrault NA, Pedersen RA et al. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology 2009: 137: 1680.
3. Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov, Accessed July 31, 2013.
4. United Network for Organ Sharing (UNOS) Database. www.unos.org. Accessed July 31, 2013.
5. Julapalli VR, Kramer JR, El-Serag HB; American Association for the Study of Liver Diseases. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl 2005: 11: 1370.
6. Eckhoff DE, McGuire BM, Young CJ et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg 1998: 4: 499.
7. Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci 2009: 54: 1794.
8. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008: 300: 2371.
9. Kemmer N. Ethnic disparities in liver transplantation. Gastroenterol Hepatol (N Y) 2011: 7: 302.
10. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002: 359: 287.
11. Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol 2008: 103: 901.
12. Neff GW, Kemmer N, Kaiser T, Zacharias V, Majoras N, Safdar K. Outcomes in adult and pediatric liver transplantation among various ethnic groups. Transplant Proc 2007: 39: 3204.
13. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010: 10: 1003.
14. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004: 10: 886.
15. Wiesner R, Edwards E, Freeman R et al. Model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003: 124: 91.
16. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PL. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000: 31: 864.
17. Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl 2003: 9: 527.
18. Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: biological, cultural, or socioeconomic factors. Hepatology 2008: 47: 1058.
19. Bryce CL, Angus DC, Arnold RM et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009: 9: 2092.
20. Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl 2004: 10: 235.
21. Reid AE, Resnick M, Chang Y, Buerstattle N, Weissman JS. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl 2004: 10: 834.
22. Lee TH, Shah N, Pedersen RA et al. Survival after liver transplantation: is racial disparity inevitable? Hepatology 2007: 46: 1491.
23. Wong RJ, Corley DA. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci 2009: 54: 2031.
24. Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg 2010: 145: 1158.
25. Artinyan A, Mailey B, Sanchez-Luege N et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010: 116: 1367.
26. Smallwood GA, Coffey G, Davis L, Martinez E, Stieber AC, Heffron TG. Hepatitis C treatment outcomes of African Americans following liver transplantation. Transplant Proc 2002: 34: 3317.
27. Brau N, Bini EJ, Currie S et al. Black patients with chronic hepatitis C have a lower sustained viral response rate than non-blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin. J Viral Hepat 2006: 13: 242.
28. Conjeevaram HS, Fried MW, Jeffers LJ et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006: 131: 470.